rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-7-25
|
pubmed:abstractText |
The purpose of this study was to evaluate incidence and risk factors of secondary leukemia after adjuvant epirubicin-based chemotherapy in breast cancer patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0923-7534
|
pubmed:author |
pubmed-author:BonneterreJJ,
pubmed-author:CamponiAA,
pubmed-author:FargeotPP,
pubmed-author:FumoleauPP,
pubmed-author:GoudierM-JMJ,
pubmed-author:KerbratPP,
pubmed-author:MonnierAA,
pubmed-author:MontcuquetPP,
pubmed-author:NamerMM,
pubmed-author:RochéHH,
pubmed-author:RomestaingPP
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1343-51
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15905306-Adult,
pubmed-meshheading:15905306-Aged,
pubmed-meshheading:15905306-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15905306-Breast Neoplasms,
pubmed-meshheading:15905306-Chemotherapy, Adjuvant,
pubmed-meshheading:15905306-Cyclophosphamide,
pubmed-meshheading:15905306-Epirubicin,
pubmed-meshheading:15905306-Female,
pubmed-meshheading:15905306-Fluorouracil,
pubmed-meshheading:15905306-Humans,
pubmed-meshheading:15905306-Incidence,
pubmed-meshheading:15905306-Leukemia, Myeloid,
pubmed-meshheading:15905306-Middle Aged,
pubmed-meshheading:15905306-Neoplasms, Second Primary,
pubmed-meshheading:15905306-Randomized Controlled Trials as Topic,
pubmed-meshheading:15905306-Risk Factors,
pubmed-meshheading:15905306-Stereoisomerism,
pubmed-meshheading:15905306-Survival Rate
|
pubmed:year |
2005
|
pubmed:articleTitle |
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
|
pubmed:affiliation |
m-campone@nantes.fnclcc.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|